| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell Carcinoma
|
Cerbone, Luigi
|
|
|
20 |
1 |
p. 80-87
|
artikel
|
| 2 |
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients
|
Martini, Dylan J.
|
|
|
20 |
1 |
p. 53-59
|
artikel
|
| 3 |
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
|
Costello, Brian A.
|
|
|
20 |
1 |
p. 1-10
|
artikel
|
| 4 |
Can Aortic and Renal Arteries Calcium Scores Be New Factors to Predict Post-Operative Renal Function After Nephron Sparing Surgery?
|
Akarken, İlker
|
|
|
20 |
1 |
p. e45-e52
|
artikel
|
| 5 |
Changing pattern of radiation therapy for bone metastases in an Australian population-based cohort of men with prostate cancer
|
Ong, Wee Loon
|
|
|
20 |
1 |
p. e7-e15
|
artikel
|
| 6 |
Clinical Characteristics and Treatment Outcomes of Testicular Myeloid Sarcomas After Hematopoietic Stem Cell Transplantation: A Single-institution Experience
|
Du, Yiqing
|
|
|
20 |
1 |
p. 88-91
|
artikel
|
| 7 |
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study
|
Pinto, Álvaro
|
|
|
20 |
1 |
p. 25-34
|
artikel
|
| 8 |
Comparative Cardiovascular Safety of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
|
Hu, Jason
|
|
|
20 |
1 |
p. 17-24
|
artikel
|
| 9 |
Correlation Between Imaging-Based Intermediate Endpoints and Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: Analysis of 28 Randomized Trials Using the Prostate Cancer Clinical Trials Working Group (PCWG2) Criteria in 16,511 Patients
|
Woo, Sungmin
|
|
|
20 |
1 |
p. 69-79
|
artikel
|
| 10 |
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma
|
Mori, Keiichiro
|
|
|
20 |
1 |
p. 95.e1-95.e6
|
artikel
|
| 11 |
Disease Progression in Older Patients With Renal Tumor Assigned to an Active Surveillance Protocol
|
Jakubowicz, Deborah
|
|
|
20 |
1 |
p. e53-e60
|
artikel
|
| 12 |
Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes
|
Venugopal, Balaji
|
|
|
20 |
1 |
p. 94-94.e10
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
20 |
1 |
p. A1
|
artikel
|
| 14 |
High Intensity Focused Ultrasound Ablation for Prostate Cancer: Whole Versus Partial Gland Ablation
|
Byun, Seok-Soo
|
|
|
20 |
1 |
p. e39-e44
|
artikel
|
| 15 |
Histological Variants of Urothelial Carcinoma Predict No Response to Neoadjuvant Chemotherapy
|
Leite, Katia Ramos Moreira
|
|
|
20 |
1 |
p. e1-e6
|
artikel
|
| 16 |
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
|
Lyou, Yung
|
|
|
20 |
1 |
p. 35-42
|
artikel
|
| 17 |
Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin
|
Curran, Catherine
|
|
|
20 |
1 |
p. 11-16
|
artikel
|
| 18 |
Perirenal Fat as a New Independent Prognostic Factor in Patients With Surgically Treated Clear Cell Renal Cell Carcinoma
|
Du, Yiqing
|
|
|
20 |
1 |
p. e75-e80
|
artikel
|
| 19 |
Predictive Impact of Early Changes in Serum C-Reactive Protein Levels in Nivolumab Plus Ipilimumab Therapy for Metastatic Renal Cell Carcinoma
|
Tachibana, Hidekazu
|
|
|
20 |
1 |
p. e81-e88
|
artikel
|
| 20 |
Prostate Cancer Characteristics and Outcomes after Prostatectomy in Asian-American Men
|
Dorff, Tanya
|
|
|
20 |
1 |
p. 92-92.e6
|
artikel
|
| 21 |
Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients
|
Horlemann, Benedikt
|
|
|
20 |
1 |
p. 93.e1-93.e9
|
artikel
|
| 22 |
Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women With Variant Histology and Advanced Stage
|
Patel, Sunil H.
|
|
|
20 |
1 |
p. 60-68
|
artikel
|
| 23 |
Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands
|
Kuppen, Malou C.P.
|
|
|
20 |
1 |
p. 43-52
|
artikel
|
| 24 |
Table of contents
|
|
|
|
20 |
1 |
p. A3-A7
|
artikel
|
| 25 |
The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost
|
Parsons, Matthew W.
|
|
|
20 |
1 |
p. e68-e74
|
artikel
|
| 26 |
The Impact of Visible Tumor (PI-RADS ≥ 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis
|
Özkan, Arif
|
|
|
20 |
1 |
p. e61-e67
|
artikel
|
| 27 |
The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments
|
Mesci, Aruz
|
|
|
20 |
1 |
p. e25-e38
|
artikel
|
| 28 |
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials
|
Alhalabi, Omar
|
|
|
20 |
1 |
p. e16-e24
|
artikel
|
Tijdschrift beschrijving